Usana Health Sciences Lowers FY2026 GAAP EPS Guidance from $(0.61) to $(0.90) vs $(0.61) Est
Benzinga Newsdesk 4 hours ago
NewsGuidance
Usana Health Sciences (NYSE:USNA) lowers FY2026 GAAP EPS guidance from $(0.61) to $(0.90) vs $(0.61) analyst estimate..
Usana Health Sciences (NYSE:USNA) lowers FY2026 GAAP EPS guidance from $(0.61) to $(0.90) vs $(0.61) analyst estimate..